| 21507/34351 | US=23-A / Câncer Takigawa N, Segawa Y, Kiura K. Secondary primary cancer following chemoradiation for non-small-cell lung cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 261-7. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; QUIMIORRADIACAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS |
| 21508/34351 | US=23-A / Câncer Gridelli C, Maione P. Advanced non-small cell lung cancer: second-line treatment with docetaxel. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 269-80. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; DOCETAXEL; TRATAMENTO |
| 21509/34351 | US=23-A / Câncer Nelli F, Moscetti L. Non-small cell lung cancer with brain metastases: platinum-based chemotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 281-9. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; METASTASES CEREBRAIS; QUIMIOTERAPIA; PLATINA |
| 21510/34351 | US=23-A / Câncer Bartolazzi A. Non-small cell lung carcinoma: EGFR gene mutations and response to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 291-306. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; MUTACOES EGFR; GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 21511/34351 | US=23-A / Câncer Kiura K, Takigawa N, Segawa Y. Advanced non-small cell lung carcinoma: acquired resistance to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 307-16. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; CARCINOMA NAO PEQUENAS CELULAS DO PULMAO AVANCADA; RESISTENCIA A GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 21512/34351 | US=23-A / Câncer Nomori H. Prognostic significance of [18F]-Fluorodeoxyglucose uptake on positron emission tomography in patients with pathological stage I lung adenocarcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 317-22. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; PROGNOSTICO; [18F]-FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS; ESTADIO PATOLOGICO I; ADENOCARCINOMA DE PULMAO |
| 21513/34351 | US=23-A / Câncer Pfannschmidt J, Bulzebruck H, Dienemann H. Non-small cell lung cancer: prognosis using the TNM staging system. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 323-36. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; PROGNOSTICO; SISTEMA TNM; CLASSIFICACAO DE TUMORES MALIGNOS |
| 21514/34351 | US=23-A / Câncer Benlloch S, Galbis-Caravajal JM, Massutí B. Differentiation between malignant and benign pleural effusions: methylation specific polymerase chain reaction analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 337-47. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; DERRAME PLEURAL MALIGNO; DERRAME PLEURAL BENIGNO; METILACAO; POLIMERASE; REACAO EM CADEIA |
| 21515/34351 | US=23-A / Câncer Hiroshima K. Pathological distinction of pulmonary large cell neuroendocrine carcinoma from small-cell lung carcinoma using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 349-61. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CARCINOMA PULMONAR DE CELULAS GRANDES; CARCINOMA DE PULMAO DE PEQUENAS CELULAS; IMUNOHISTOQUIMICA; CARCINOMA DE GRANDES CELULAS NEUROENDOCRINO; MORFOMETRIA; BIOLOGIA MOLECULAR |
| 21516/34351 | US=23-A / Câncer Zander DS, Clarke LE. Differentiation between pleuropulmonary desmoid tumors and solitary fibrous tumors: role of histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 363-9. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; TUMORES PLEUROPULMONARES DESMOIDE; TUMORES FIBROSOS SOLITARIOS; HISTOLOGIA; IMUNOHISTOQUIMICA; PATOLOGIA MACROSCOPICA; PATOLOGIA MICROSCOPICA |
| 21517/34351 | US=23-A / Câncer Ma ESK, Wong CLP. Non-small cell lung cancer with brain metastasis: role of epidermal growth factor receptor gene mutation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 371-87. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; METASTASE CEREBRAL; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; MUTACAO DO GENE |
| 21518/34351 | US=23-A / Câncer Hayat MA. Prostate carcinoma. In: ___. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 391-6. ISBN 978-1-4020-8441-62. |
| 21519/34351 | US=35 / Estatística Chen Z, Rushton G, Smith G. Preserving privacy: deidentifying data by applying a randon perturbation spatial mask. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 139-46. ISBN 0-8493-8419-2. |
| 21520/34351 | US=35 / Estatística Waller LA. Spatial statistical analysis of point and area-referenced public health data. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 147-63. ISBN 0-8493-8419-2. ANALISE ESTATISTICA; REFERENCIAS DE DADOS DE SAUDE PUBLICA; ANALISE DE DADOS DE LOCALIZACAO DE PONTOS; ANALISE DE DADOS DE CONTAGEM DE AREA |
| 21521/34351 | US=23-A / Câncer Franklin RB, Costello LC. The role of intermediary metabolism and molecular genetics in prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 397-413. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; METABOLISMO INTERMEDIARIO; GENETICA MOLECULAR; CITRATO; M-ACONITASE; ZINCO; GLUCOSE; ASPARTATO; OXALACETATO; BIOENERGETICOS; LIPOGENESE |
| 21522/34351 | US=35 / Estatística Zimmerman DL. Statistical methods for incompletely and incorrectly geocoded cancer data. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 165-80. ISBN 0-8493-8419-2. METODOS ESTATISTICOS; DADOS DE CANCER; GEOCODIFICADOS; ANALISE DE DADOS DE FORMA INCOMPLETA GEOCODIFICADOS; PSEUDOCODIGO; LOCALIZACAO DADOS DE PONTO |
| 21523/34351 | US=23-A / Câncer Ribeiro FR, Skotheim RI, Henrique R, Teixeira MR. Array-based comparative genomic hybridization in prostate cancer: research and clinical applications. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 415-29. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; HIBRIDIZACAO GENOMICA COMPARATIVA |
| 21524/34351 | US=35 / Estatística Armstrong M, Greene BR, Rushton G. Using geocodes to estimate distances and geographic accessibility for cancer prevention and control. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 181-94. ISBN 0-8493-8419-2. USANDO GEOCODES; ACESSIBILIDADE GEOGRAFICA. PREVENCAO E CONTROLE DO CANCER; METRICAS DE DISTANCIA; METODOS DE CALCULOS; REDES; ATRIBUTOS LIGACAO; MEDIR A ACESSIBILIDADE GEOGRAFICA; MAPEAR A ACESSIBILIDADE GEOGRAFICA |
| 21525/34351 | US=23-A / Câncer Lu S. Prostate cancer: role of Vav3 overexpression in development and progression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 431-9. ISBN 978-1-4020-8441-62. |
| 21526/34351 | US=35 / Estatística Gittler J. Cancer registry data and geocoding: privacy, confidentiality, and security issues. In: Rushton G, Armstrong MP, Gittler J, Greene BR, Pavlik CE, West MM, Zimmerman DL. Geocoding health data: the use of geographic codes in cancer prevention and control research and practice. New York: Taylor & Francis, 2008. p. 195-223. ISBN 0-8493-8419-2. DADOS DE REGISTRO DE CANCER; GEORREFERENCIAMENTO; PRIVACIDADE DE INFORMACOES; NOTIFICACAO DE CASOS DE CANCER; DADOS GEORREFERENCIADOS DE CANCER. CONFIDENCIAIS |